2024
Kelsh M , Bylsma LC, Jiang X, Movva N , Sacks NC . To be an orphan disease or not to be: An evaluation of prevalence estimates for cancers near the orphan status threshold and implications for orphan drug planning. International Society for Pharmacoepidemiology, 40th Annual Meeting, Berlin, Germany, August 2024.
Topics: Epidemiology , Health Economics and Outcomes Research (HEOR)
Suh M, Mittal L, Brorby G, Pastula S, Vincent M, Proctor D . Epidemiology is critical in advancing cumulative impact assessment (CIA) research: A pilot study in San Antonio, Texas. International Society of Exposure Science, Montreal, Canada, October 2024.
View Abstract
Topics: Epidemiology
Vincent M , Fitch S , Bylsma L , Thompson C , Rogers S , Britt J , Wikoff D . Integration of toxicological and epidemiological information to evaluate biological plausibility and causality of associations between inhaled formaldehyde (FA) and lymphohematopoietic (LHP) cancers. Abstract 5157, Society of Toxicology Annual Meeting, Salt Lake City, UT, March 2024.
View Abstract
Topics: Cancer , Epidemiology , Toxicology
Perry CS , Vivanco SN , Verwiel AH , Proctor DM . Derivation of manganese 24-hour acute inhalation guideline protective of respiratory and neurological effects. Abstract 4751, Society of Toxicology Annual Meeting, Salt Lake City, UT, March 2024.
View Abstract
Topics: Toxicology
Borghoff SJ , Feifarek D , Mihalchik A , Heintz M , Haws L , Nyambego H, Goyak K, Lea IA . Evaluation of the endocrine disrupting potential of di-isononyl phthalate . Abstract 3931, Society of Toxicology Annual Meeting, Salt Lake City, UT, March 2024.
View Abstract
Topics: Toxicology
Allen B, Vincent M , Lipword L, Panko J , Suh M , Jiang X , Mumma, Proctor D . Lung cancer risk and exposure to hexavalent chromium: Results of extended mortality study of workers with low level exposures and quantitative risk assessment using pooled analysis of three cohorts. Society of Toxicology Annual Meeting, Salt Lake City, UT, March 2024.
Topics: Hexavalent Chromium , Toxicology
Yoshino T, Hooda N , Younan D, Shitara K, Heinemann V,… Suh M , Reichert H , et al. 2023. 127P A meta-analysis of efficacy and safety from head-to-head first-line (1L) trials of epidermal growth factor receptor inhibitors (EGFRIs) versus bevacizumab in combination with chemotherapy (CT) doublets in patients with RAS wild-type (WT) metastatic colorectal cancer (mCRC) by sidedness. Ann Oncol 34(Suppl 4):S1519 [abstract]; DOI:https://doi.org/10.1016/j.annonc.2023.10.262.
View Abstract
Topics: Cancer , Epidemiology
2023
Franklin M, Emden MR, Bauer E, Nguyen AT, Sacks N , Kawamatsu S, Kawano Y, Mitrani-Gold FS, Joshi AV, Ju S, Preib MT. Prevalence of acute uncomplicated cystitis in Japan. Poster presentation, IDWeek, October 2023.
Topics: Health Economics and Outcomes Research (HEOR)
Franklin M, Emden MR, Kautz S, Nguyen AT, Sacks NC , Ju S, Mitrani-Gold FS, Joshi AV, Preib MT. Cost burden of patients with oral antibiotic treatment failure for uncomplicated urinary tract infection in the United States. Poster presentation, IDWeek, October 2023.
Topics: Health Economics and Outcomes Research (HEOR)
Nelson CB, Jiang X , Suh M , Fryzek J. Prevention of respiratory syncytial virus hospitalizations (RSVH) in US infants who paid through Medicaid would have a greater benefit for Black, Hispanic, Asian/Pacific Islander, Native American and Other race/ethnicity infants, and have a substantial impact on overall RSVH burden and related costs: Rates of respiratory syncytial virus hospitalization (RSVH) among US infants by race/ethnicity and insurance payer, NIS 2018-2020. Poster 1536169, IDWeek 2023, Boston, MA, October 2023.
A Division of